Concord Medical Services Holdings Limited

Symbol: CCM

NYSE

0.52

USD

Market price today

  • -0.9214

    P/E Ratio

  • 0.0139

    PEG Ratio

  • 14.64M

    MRK Cap

  • 0.00%

    DIV Yield

Concord Medical Services Holdings Limited (CCM) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

-0.14%

Operating Profit Margin

-0.86%

Net Profit Margin

-0.55%

Return on Assets

-0.03%

Return on Equity

0.10%

Return on Capital Employed

-0.07%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Care Facilities
CEO:Dr. Jianyu Yang
Full-time employees:918
City:Beijing
Address:Tower A, Global Trade Center
IPO:2009-12-11
CIK:0001472072

Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

General Outlook

When we look at how much money they make before expenses, they keep -0.142% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.861%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.553%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.031% return, is a testament to Concord Medical Services Holdings Limited's adeptness in optimizing resource deployment. Concord Medical Services Holdings Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.095%. Furthermore, the proficiency of Concord Medical Services Holdings Limited in capital utilization is underscored by a remarkable -0.072% return on capital employed.

Stock Prices

Concord Medical Services Holdings Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.9, while its low point bottomed out at $0.551. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Concord Medical Services Holdings Limited's stock market.

Liquidity Ratios

Analyzing CCM liquidity ratios reveals its financial health of the firm. The current ratio of 31.63% gauges short-term asset coverage for liabilities. The quick ratio (6.75%) assesses immediate liquidity, while the cash ratio (2.98%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio31.63%
Quick Ratio6.75%
Cash Ratio2.98%

Profitability Ratios

CCM profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -104.13% underscores its earnings before tax deductions. The effective tax rate stands at -2.44%, revealing its tax efficiency. The net income per EBT, 53.08%, and the EBT per EBIT, 120.94%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -86.10%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-104.13%
Effective Tax Rate-2.44%
Net Income per EBT53.08%
EBT per EBIT120.94%
EBIT per Revenue-86.10%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.32, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding7
Days of Inventory Outstanding37
Operating Cycle115.22
Days of Payables Outstanding120
Cash Conversion Cycle-5
Receivables Turnover4.69
Payables Turnover3.05
Inventory Turnover9.76
Fixed Asset Turnover0.09
Asset Turnover0.06

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -17.04, and free cash flow per share, -26.19, depict cash generation on a per-share basis. The cash per share value, 1.34, showcases liquidity position. Lastly, the operating cash flow sales ratio, -2.15, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-17.04
Free Cash Flow per Share-26.19
Cash per Share1.34
Operating Cash Flow Sales Ratio-2.15
Free Cash Flow to Operating Cash Flow Ratio1.54
Cash Flow Coverage Ratio-0.22
Short Term Coverage Ratio-0.68
Capital Expenditure Coverage Ratio-1.86
Dividend Paid and Capex Coverage Ratio-1.86

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 54.44%, highlights its total liabilities relative to assets. With a debt-equity ratio of -1.55, we discern the balance between debt and equity financing. The long-term debt to capitalization, 2594.18%, and total debt to capitalization, 280.78%, ratios shed light on its capital structure. An interest coverage of -12.68 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio54.44%
Debt Equity Ratio-1.55
Long Term Debt to Capitalization2594.18%
Total Debt to Capitalization280.78%
Interest Coverage-12.68
Cash Flow to Debt Ratio-0.22
Company Equity Multiplier-2.85

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 12.30, provides a glimpse into top-line earnings distributed across each share. Net income per share, -6.81, reflects the portion of profit attributed to each share. The book value per share, -48.57, represents the net asset value distributed per share, while the tangible book value per share, 10.31, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share12.30
Net Income Per Share-6.81
Book Value Per Share-48.57
Tangible Book Value Per Share10.31
Shareholders Equity Per Share-48.57
Interest Debt Per Share79.24
Capex Per Share-2.74

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 13.84%, indicates top-line expansion, while the gross profit growth, 49.74%, reveals profitability trends. EBIT growth, 11.82%, and operating income growth, 11.82%, offer insights into operational profitability progression. The net income growth, 61.29%, showcases bottom-line expansion, and the EPS growth, 61.31%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth13.84%
Gross Profit Growth49.74%
EBIT Growth11.82%
Operating Income Growth11.82%
Net Income Growth61.29%
EPS Growth61.31%
EPS Diluted Growth61.31%
Operating Cash Flow Growth-27.59%
Free Cash Flow Growth34.10%
10-Year Revenue Growth per Share-43.17%
5-Year Revenue Growth per Share179.47%
3-Year Revenue Growth per Share140.98%
10-Year Operating CF Growth per Share-210.01%
5-Year Operating CF Growth per Share-611.23%
3-Year Operating CF Growth per Share-20.33%
10-Year Net Income Growth per Share-447.23%
5-Year Net Income Growth per Share-25.81%
3-Year Net Income Growth per Share26.33%
10-Year Shareholders Equity Growth per Share-202.95%
5-Year Shareholders Equity Growth per Share-581.59%
3-Year Shareholders Equity Growth per Share-220.07%
Receivables Growth-85.67%
Inventory Growth-52.44%
Asset Growth0.82%
Book Value per Share Growth-13.84%
Debt Growth1.72%
SGA Expenses Growth3.69%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 3,578,609,131.072, captures the company's total value, considering both debt and equity. Income quality, 0.52, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 21.42%, indicates the value of non-physical assets, and capex to operating cash flow, 43.37%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value3,578,609,131.072
Income Quality0.52
Sales General and Administrative to Revenue0.61
Intangibles to Total Assets21.42%
Capex to Operating Cash Flow43.37%
Capex to Revenue-22.31%
Capex to Depreciation-93.35%
Graham Number86.30
Return on Tangible Assets-6.26%
Graham Net Net-95.54
Working Capital-1,334,186,000
Tangible Asset Value450,414,000
Net Current Asset Value-3,689,748,000
Invested Capital-2
Average Receivables293,158,500
Average Payables137,992,000
Average Inventory62,591,000
Days Sales Outstanding50
Days Payables Outstanding77
Days of Inventory On Hand24
ROIC-37.70%
ROE0.14%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -0.08, and the price to book ratio, -0.08, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.52, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.16, and price to operating cash flows, -0.24, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio-0.08
Price to Book Ratio-0.08
Price to Sales Ratio0.52
Price Cash Flow Ratio-0.24
Price Earnings to Growth Ratio0.01
Enterprise Value Multiple14.08
Price Fair Value-0.08
Price to Operating Cash Flow Ratio-0.24
Price to Free Cash Flows Ratio-0.16
Price to Tangible Book Ratio-0.16
Enterprise Value to Sales6.66
Enterprise Value Over EBITDA-11.41
EV to Operating Cash Flow-12.94
Earnings Yield-87.28%
Free Cash Flow Yield-116.23%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Concord Medical Services Holdings Limited (CCM) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.921 in 2024.

What is the ticker symbol of Concord Medical Services Holdings Limited stock?

The ticker symbol of Concord Medical Services Holdings Limited stock is CCM.

What is company IPO date?

IPO date of Concord Medical Services Holdings Limited is 2009-12-11.

What is company current share price?

Current share price is 0.520 USD.

What is stock market cap today?

The market cap of stock today is 14640381.000.

What is PEG ratio in 2024?

The current 0.014 is 0.014 in 2024.

What is the number of employees in 2024?

In 2024 the company has 918.